Over the next ten years, the fibrotic diseases treatment landscape will undergo profound transformation. Novel mechanisms of action, precision diagnostics, and personalized medicine are redefining how these diseases are managed. The global rise in chronic disorders, environmental stressors, and aging populations continues to fuel the demand for better fibrotic treatments. Pharmaceutical giants...